IL33 and liver disorder: To assess whether activation of ST2+ Tregs by exogenous IL-33 is critical for the immunosuppressive effect of this cytokine on liver disease pathology, we treated Foxp3Cre x ST2fl/fl mice (21) with IL-33 before induction of hepatitis.